SecBot SecBot
6-K ·Filed Jun 1, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001654954-26-005587
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine employee share issuance with immaterial dilution. No trading action warranted. Monitor for any future material filings such as earnings or pipeline updates.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$179.55
T+0 close · Jun 1, 2026 · via day close
Latest settled
−5.55%
T+60 · $169.59
Vs SPY
−6.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 1 $179.55entry
  2. T+1 · 6mo ago −1.20%α −1.35% · $177.39
  3. T+5 · 5mo ago +3.57%α +6.32% · $185.95
  4. T+20 · 5mo ago +6.35%α +8.66% · $190.95
  5. T+60 · 3mo ago −5.55%α −6.52% · $169.59

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AstraZeneca filed a 6-K reporting the admission of 14,120 ordinary shares to trading on the London Stock Exchange, issued under an existing employee share scheme block admission from January 2021. This is a routine administrative filing with no material financial or strategic impact.

Key Facts

  • 14,120 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange Main Market.
  • Total shares in issue post-admission: 1,551,009,750.
  • Shares were issued under an existing block admission dated 29 January 2021 for employee share schemes.
  • The admission covers shares issued between 1 May 2026 and 31 May 2026.
  • No prospectus or supplementary prospectus was filed.

Financial Impact

Dilution from 14,120 new shares is negligible, approximately 0.0009% of total shares outstanding.

dilution

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-005587
Document: 0001654954-26-005587-index-headers.html0001654954-26-005587
Document: 0001654954-26-005587-index.html0001654954-26-005587
Document: 0001654954-26-005587.txt0001654954-26-005587

Track record

77 reports on AZN

Performance horizon

19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
  2. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.02 −0.82% settles Nov 23
  3. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.02 −0.70% settles Nov 23
  4. Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.02 −0.58% settles Nov 23
  5. Nov 4, 202611d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.02 −1.51% ▼ −1.32% −4.61% vs SPY
  6. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
  7. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.02 −1.37% ▲ +1.51% +1.43% vs SPY
  8. Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.02 −1.41% ▼ −0.12% +2.59% vs SPY
  9. Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.02 +8.20% ▲ +8.11% +10.10% vs SPY
  10. Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.02 +6.63% ▲ +0.51% −0.19% vs SPY
Showing 10 of 77

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026